Literature DB >> 11545270

Vaccinia virus-free recovery of vesicular stomatitis virus.

R N Harty1, M E Brown, F P Hayes, N T Wright, M J Schnell.   

Abstract

The advent of reverse-genetics represents a powerful new approach to elucidate aspects of negative-sense RNA virus replication. The reverse-genetics system established previously for vesicular stomatitis virus (VSV) required four plasmids encoding the nucleoprotein (N), phosphoprotein (P), polymerase (L), and the full-length, anti-genomic RNA. Transcription to yield the antigenomic RNA as well as the N, P, and L, mRNAs was initiated by bacteriophage T7 polymerase expressed from a recombinant Vaccinia virus. In this report, we describe the successful recovery of infectious VSV in the absence of Vaccinia virus. The N, P, and L genes of VSV were inserted downstream of both the T7 promoter and an internal ribosomal entry site (IRES element). T7 polymerase was expressed constitutively from BSR-T7/5 cells. RTPCR was used to confirm that the recovered VSV was derived from transfected DNA. Virion protein profile, CPE in tissue culture, and virus titer of the recombinant VSV were indistinguishable from those of parental VSV. Thus, the need for Vaccinia virus is eliminated with this system, making it an attractive, alternative approach for the recovery of infectious VSV from DNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545270

Source DB:  PubMed          Journal:  J Mol Microbiol Biotechnol        ISSN: 1464-1801


  8 in total

Review 1.  Rhabdoviruses as vectors for vaccines and therapeutics.

Authors:  Gabrielle Scher; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2020-10-29       Impact factor: 7.090

2.  Rhabdovirus-based vaccine platforms against henipaviruses.

Authors:  Drishya Kurup; Christoph Wirblich; Heinz Feldmann; Andrea Marzi; Matthias J Schnell
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

3.  Inducible vesicular stomatitis virus (VSV) L cell line for packaging of recombinant VSV.

Authors:  Seong-Karp Hong; Yong-Tae Jung; Seung-Won Park; Soon-Young Paik
Journal:  Virus Genes       Date:  2005-10       Impact factor: 2.198

4.  Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever.

Authors:  Tiago Abreu-Mota; Katie R Hagen; Kurt Cooper; Peter B Jahrling; Gene Tan; Christoph Wirblich; Reed F Johnson; Matthias J Schnell
Journal:  Nat Commun       Date:  2018-10-11       Impact factor: 14.919

Review 5.  RNA Viruses as Tools in Gene Therapy and Vaccine Development.

Authors:  Kenneth Lundstrom
Journal:  Genes (Basel)       Date:  2019-03-01       Impact factor: 4.096

Review 6.  Self-replicating vehicles based on negative strand RNA viruses.

Authors:  Kenneth Lundstrom
Journal:  Cancer Gene Ther       Date:  2022-02-15       Impact factor: 5.854

7.  The Multiplicity of Infection of Recombinant Vaccinia Virus Expressing the T7 RNA Polymerase Determines the Rescue Efficiency of Vesicular Stomatitis Virus.

Authors:  Fan Yang; Jinlong Tan; Yongxiang Fang; Guohua Chen; Yongzhi Zhang; Qianqian Hu; Wuweiyi Han; Yongsheng Liu; Baoquan Fu; Zhizhong Jing; Weike Li
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

Review 8.  Replicon RNA Viral Vectors as Vaccines.

Authors:  Kenneth Lundstrom
Journal:  Vaccines (Basel)       Date:  2016-11-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.